Related Experiment Video
Updated: Apr 2, 2026

08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
11.4K
Clinical Profile, Outcome and Risk Factors for Mortality Among Children Admitted with Critical Pertussis: An
Asruti Kacha1, Pareshkumar Amrutlal Thakkar2, Dhairya Gandhi1
1Department of Pediatrics, Government Medical College Baroda and SSG Hospital, Vadodara, Gujarat, 390001, India.
Indian Pediatrics
|April 1, 2026
Summary
Critical pertussis in children often presents as severe pneumonia, caused by Bordetella species. Shock is a significant predictor of mortality in these severe cases.
Area of Science:
- Pediatric Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Pertussis, also known as whooping cough, remains a significant public health concern globally.
- Critical pertussis in infants and young children can lead to severe respiratory distress and high mortality rates.
- Understanding the clinical spectrum and risk factors is crucial for timely intervention.
Purpose of the Study:
- To investigate the clinical and microbiological characteristics of critical pertussis in children.
- To identify outcomes and risk factors associated with mortality in pediatric intensive care unit (PICU) patients with critical pertussis.
- To determine the etiological agents responsible for severe pertussis cases.
Main Methods:
- An ambispective study was conducted on 75 children diagnosed with critical pertussis and admitted to the PICU.
- Diagnosis was confirmed using real-time polymerase chain reaction (PCR).
- Clinical data, complications, and patient outcomes, including mortality, were systematically recorded.
Main Results:
- Bordetella infection was confirmed in 76% of cases (34 B. pertussis, 23 other Bordetella species).
- Common symptoms included fever, paroxysmal cough, and tachypnea, with all patients showing diffuse infiltrates on chest X-ray.
- High rates of complications were observed: hypoxemia (92%), shock (54.7%), encephalopathy (50.7%), and seizures (38.7%).
- Mechanical ventilation was required for 84% of patients, and 50.7% expired.
- Shock emerged as an independent risk factor for mortality (aOR 7.63, P=0.002).
Conclusions:
- Critical pertussis frequently manifests as severe pneumonia and can be attributed to both B. pertussis and other Bordetella species.
- The presence of shock significantly increases the risk of mortality in children suffering from critical pertussis.
- Early recognition of shock is vital for improving outcomes in severe pertussis cases.
Related Concept Videos
Pneumonia III: Complications and Assessment
1.2K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia I: Introduction
1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia II: Pathophysiology
4.2K
The pathophysiology of pneumonia involves the following steps:
4.2K
Acute Respiratory Failure-II
1.5K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K
Atypical Pneumonia
41
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
41
